Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Insulin Resistance 1 Hypoglycemia 1 Fatigue 1 Cachexia 1

Interventions

Metformin 139 Clomiphene 44 Letrozole 36 Inositol 28 Folic Acid 17 Exercise 17 Progesterone 16 Ethinyl Estradiol 13 Caloric Restriction 13 drospirenone and ethinyl estradiol combination 12 Estradiol 12 Contraceptives, Oral 11 cetrorelix 10 Pioglitazone 10 High-Intensity Interval Training 10 Chorionic Gonadotropin 10 Triptorelin Pamoate 9 Tablets 9 Spironolactone 8 Diet 8 Cholecalciferol 8 Vitamin D 7 Thioctic Acid 7 Surveys and Questionnaires 7 Menotropins 7 Liraglutide 7 Gonadotropins 7 Acupuncture Therapy 7 drospirenone 6 Ovidrel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Polycystic Ovary Syndrome × Flour × Clear all

NCT00970541 2021-08-25

Eccentric

Pennington Biomedical Research Center

Phase 1 Terminated

Hypoglycemia, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡